Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke

BACKGROUND AND PURPOSE: In a recent pooled analysis of randomized clinical trials (RCTs), intravenous tissue plasminogen activator (TPA) improves the outcome in patients aged ≥80 years. However, it is uncertain whether the findings are applicable to clinical practice in Asian populations. METHODS: F...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jay Chol, Lee, Ji Sung, Park, Tai Hwan, Park, Sang-Soon, Cho, Yong-Jin, Park, Jong-Moo, Kang, Kyusik, Lee, Kyung Bok, Lee, Soo-Joo, Ko, Youngchai, Kim, Jae Guk, Lee, Jun, Cho, Ki-Hyun, Kim, Joon-Tae, Yu, Kyung-Ho, Lee, Byung-Chul, Oh, Mi-Sun, Cha, Jae-Kwan, Kim, Dae-Hyun, Nah, Hyun-Wook, Kim, Dong-Eog, Ryu, Wi-Sun, Kim, Beom Joon, Bae, Hee-Joon, Kim, Wook-Joo, Shin, Dong-Ick, Yeo, Min-Ju, Sohn, Sung Il, Hong, Jeong-Ho, Lee, Juneyoung, Hong, Keun-Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635722/
https://www.ncbi.nlm.nih.gov/pubmed/26437998
http://dx.doi.org/10.5853/jos.2015.17.3.327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635722/
https://www.ncbi.nlm.nih.gov/pubmed/26437998
http://dx.doi.org/10.5853/jos.2015.17.3.327

Ejemplares similares